Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01340
|
|||||
| Drug Name |
Nafoxidine
|
|||||
| Synonyms |
Nafoxidine; 1845-11-0; Nafoxidine [INN]; Nafoxidinum [INN-Latin]; Nafoxidina [INN-Spanish]; UNII-4RIY10WM82; U-11000A; BRN 1440873; CHEMBL28211; 4RIY10WM82; CHEBI:34881; NSC 70735; C29H31NO2; JEYWNNAZDLFBFF-UHFFFAOYSA-N; 1-(2-(p-(3,4-Dihydro-6-methoxy-2-phenyl-1-naphthyl)phenoxy)ethyl)pyrrolidine; Pyrrolidine, 1-(2-(4-(3,4-dihydro-6-methoxy-2-phenyl-1-naphthalenyl)phenoxy)ethyl)-; 1-[2-[4-(6-methoxy-2-phenyl-3,4-dihydronaphthalen-1-yl)phenoxy]ethyl]pyrrolidine; Pyrrolidine, 1-(2-(p-(3,4-dihydro-6-methoxy-2-phenyl-1-naphthyl
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Advanced breast cancer [ICD11: 2C60-2C6Z] | Preclinical | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C29H31NO2
|
|||||
| Canonical SMILES |
COC1=CC2=C(C=C1)C(=C(CC2)C3=CC=CC=C3)C4=CC=C(C=C4)OCCN5CCCC5
|
|||||
| InChI |
InChI=1S/C29H31NO2/c1-31-26-14-16-28-24(21-26)11-15-27(22-7-3-2-4-8-22)29(28)23-9-12-25(13-10-23)32-20-19-30-17-5-6-18-30/h2-4,7-10,12-14,16,21H,5-6,11,15,17-20H2,1H3
|
|||||
| InChIKey |
JEYWNNAZDLFBFF-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 1845-11-0
|
|||||
| Pharmaceutical Properties | Molecular Weight | 425.6 | Topological Polar Surface Area | 21.7 | ||
| Heavy Atom Count | 32 | Rotatable Bond Count | 7 | |||
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 3 | |||
| XLogP |
5.8
|
|||||
| PubChem CID | ||||||
| PubChem SID |
794529
, 5096570
, 7847022
, 8152730
, 14905117
, 29223513
, 48110654
, 48421892
, 50038542
, 53788181
, 57322262
, 77903400
, 93165515
, 103195570
, 103960656
, 104306343
, 124899377
, 125669770
, 126665811
, 128265252
, 128265253
, 134349497
, 134980548
, 137009443
, 142396265
, 178101080
, 179150105
, 198983433
, 223442309
, 223662464
, 223860366
, 226517813
, 250095402
|
|||||
| ChEBI ID |
CHEBI:34881
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Hormones and Breast Cancer. | |||||
| 2 | Antiestrogens and steroid hormones: substrates of the human P-glycoprotein. Biochem Pharmacol. 1994 Jul 19;48(2):287-92. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.